Pharmacology of polyprenols from Ginkgo biloba L. leaves in combination with chemotherapeutic drugs on tumor

Linchan Huaxue Yu Gongye/Chemistry and Industry of Forest Products

Volumn 23, Issue 3, 2003, Pages 15-18

  Wang, Cheng Zhang ^a   Shen, Zhao Bang ^a   Gao, Ling ^b  

^a RESEARCH INSTITUTE OF FORESTRY   (China)

^b Jiangsu Institute of Prophylactic and Therapeutic Cancer   (China)

Author keywords

Ginkgo biloba L. leaves; Polyprenols; S180; Subsidiary chemotherapy; Tumor

Indexed keywords

ALCOHOLS; CHEMOTHERAPY; DETOXIFICATION; DRUG INTERACTIONS; PHARMACODYNAMICS; TOXICITY; TUMORS;

CHEMOTHERAPEUTIC DRUGS; GINKGO BILOBA L. LEAVES; POLYPRENOLS; SUBSIDIARY CHEMOTHERAPY;

WOOD CHEMICALS;

DRUGS; LEAVES; PHARMACOLOGY; PRENOLS; TUMORS;

EID: 0742266864     PISSN: 02532417     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (8)

1. JANKOWSKI W J, et al. Uptake and metabolism of exogenous polyprenols by animal cells[J]. Chemica Scripta, 1987, 27: 5-9.
2. KUZNETSOVS S, DAUGAVIETIS M. Effects of plant polyprenols on P-388 Leukemia cell sensitivity and chemotherapy resistance in vitro[A]. 18th International Congress of Chemotherapy[C]. Stochholm, 1994. 170.
3. ROSHCHIN V, et al. Immunomodulating agent[P]. RU Patent: 2137479, 1999-03-22.
4. OKAMOTO Y, et al. Pharmaceutical compositions for the inhibition of tumor metastasis[P]. US Patent: 5004735, 1991-04-02.
5. KUZNETSOVS S, DAUGAVIETIS M. Biochemical and immunologic aspects of plant polyprenols on the experimental multiple sclerosis[A]. Proceedings of a Satellite Meeting to the 11th International Symposium on Glycoconjugates[G]. Canada, 1998. 31, 49.